No significant difference between KIF20A protein expression and other clinicopathological features, such as age, SCC-Ag, tumor size, differentiation grade, myometrium invasion, or infiltration of the parauterine organ was observed (P > 0.05; Table 2). This evidence concerns the gene KIF20A and neoplasm.